Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim — Stella

Home/Duchenne Muscular Dystrophy/Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim

View on ClinicalTrials.gov

Recruiting

Back to Duchenne Muscular Dystrophy trials

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim

Trial locations(1 site)

United States

Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Sponsor

Vanderbilt University Medical Center

Enrollment target

~10 participants

Started

July 2024

Primary completion

December 2029

Age range

10 Years and older

Sex

Male only

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.